| Kyle Vaitukaitis, | |
|
19869 Sea Blossom Blvd, Rehoboth Beach, DE 19971-7142 | |
| (302) 226-7791 | |
| Not Available |
| Full Name | Kyle Vaitukaitis |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 19869 Sea Blossom Blvd, Rehoboth Beach, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295288645 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | A1-0004965 (Delaware) | Secondary |
| 183500000X | Pharmacist | 24206 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Vaitukaitis, 10620 Pine Needle Rd, Ocean City, MD 21842-4838 Ph: (410) 982-7300 | Kyle Vaitukaitis, 19869 Sea Blossom Blvd, Rehoboth Beach, DE 19971-7142 Ph: (302) 226-7791 |
News Archive
Led by Dr. Peiyee Lee and Dr. Richard Gatti, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have used induced pluripotent stem cells to advance disease-in-a-dish modeling of a rare genetic disorder, ataxia telangiectasia.
Heart disease, which was once an illness affecting adults, is now a major concern among children. In fact, many studies have shown that the risks of cardiovascular disease pile up since childhood, hence, starting to educate them about practicing a healthy lifestyle is crucial to prevent the development of chronic and potentially-fatal diseases in the future.
LYSOL((R)), the number one pediatrician recommended brand, announced today the launch of the Healthier Habits Rewards Program, an initiative to educate families on healthy hygiene routines. Through the Healthier Habits Rewards program, parents can learn valuable tips to help protect themselves and their children from potential illness-causing germs at home or at school.
BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called Accurins, announced today the presentation of late-breaker clinical data for BIND-014, the lead drug candidate within a new class of targeted therapeutics that are programmed to concentrate at tumors, at the American Association for Cancer Research (AACR) 2012 Annual Meeting.
› Verified 6 days ago
Amber Haynes, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 19312 Lighthouse Plaza Blvd, Rehoboth Beach, DE 19971 Phone: 302-227-5954 | |
Mrs. Amy Lynn Antos, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 18993 Munchy Branch Rd, Rehoboth Beach, DE 19971 Phone: 302-226-0220 | |
Mrs. Wendy C Destasio, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 18578 Coastal Hwy, Acme, Rehoboth Beach, DE 19971 Phone: 302-644-1903 Fax: 302-644-1906 | |
Kathleen Mcguiness, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Broad Hollow St, Rehoboth Beach, DE 19971 Phone: 302-245-7355 | |
Walter Robert Beck, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 19312 Lighthouse Plaza Blvd, Rehoboth Beach, DE 19971 Phone: 302-227-5954 Fax: 844-411-6344 | |
Dr. Heather M Sheridan Revel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 19869 Sea Blossom Blvd, Rehoboth Beach, DE 19971 Phone: 302-226-7791 Fax: 302-226-7796 |